GB464396A - Process for the manufacture of androstenol-(17)-ones-(3) and derivatives thereof - Google Patents

Process for the manufacture of androstenol-(17)-ones-(3) and derivatives thereof

Info

Publication number
GB464396A
GB464396A GB2509235A GB2509235A GB464396A GB 464396 A GB464396 A GB 464396A GB 2509235 A GB2509235 A GB 2509235A GB 2509235 A GB2509235 A GB 2509235A GB 464396 A GB464396 A GB 464396A
Authority
GB
United Kingdom
Prior art keywords
oxidized
brominated
hydroxy
debrominated
androstendiol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2509235A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering Kahlbaum AG
Original Assignee
Schering Kahlbaum AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Kahlbaum AG filed Critical Schering Kahlbaum AG
Priority to GB2509235A priority Critical patent/GB464396A/en
Publication of GB464396A publication Critical patent/GB464396A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Abstract

17-Hydroxy-3-keto compounds of the cyclopentanopolyhydrophenanthrene series are prepared by subjecting saturated or unsaturated 3 : 17-dihydroxy compounds of the androstane series to the action of agents capable of transforming a secondary alcohol group into a keto group. As starting materials there are used both saturated and unsaturated compounds of the androstane series, and particularly those compounds which possess a hydrocarbon radical on position 17, such as alkyl-androstandiols and androstendiols-3-17. The oxidation may be performed directly on the free diols, especially when the carbon atom 17 is substituted by a hydrocarbon radical, or the 17-hydroxy group may be protected by convertion into a group which on hydrolysis can be re-converted into a hydroxy group such as an ether, ester or halogen group. In the case of unsaturated starting materials it is preferred to protect the nuclear double bond by the addition of halogen or halogen hydride. The 17-hydroxy-3-keto compounds may be isolated from the reaction mixture by the usual methods of fractional crystallization, distillation or sublimation. Use may also be made of keto reagents and acylating agents capable of yielding difficultly soluble esters. Saponines such as digitonine are particularly useful for separation of nonreacted diol compounds. If desired, the 17-derivatives of the 17-hydroxy-3-keto compounds prepared according to the invention may be converted into the free hydroxy compounds or alternatively if the free hydroxy body has been produced it may be subsequently esterified, etherified or halogenated. In examples: (1) a glacial acetic acid solution of androstendiolmonoacetate-17 is brominated, oxidized with chromium trioxide, and debrominated with sodium iodide to yield an ester which on saponification gives a hydroxy-ketone identical with the natural material extracted from the testicles of bulls; (2) androstendiol-monoacetate-17 brominated and oxidized as in example (1) is debrominated by zinc dust to give on saponification the same keto-alcohol. Reaction of this keto-alcohol with benzoyl chloride produces the 17-benzoic acid ester which is of particular physiological value; (3) 17-methyl-androstandiol-3-17 is oxidized in glacial acetic acid solution with chromium trioxide at room temperature for 12 hours, to give 17-methyl-androstanol-17-one-3; (4) 17-methyl androstendiol-3-17 is brominated and then oxidized as in example 3. After debromination with zinc dust, a hydroxy ketone is obtained; (5) 3-hydroxy-17-chlorandrostene is brominated, oxidized, and debrominated as in example (4) to give 17-chlorandrostenone - 3; (6) androstendiol - 3 - 17 is brominated, oxidized and debrominated as in example (4). The product is then treated with digitonine and the digitonide of the dehydroandrosternone formed in the oxidation is obtained. This is removed and the residue treated with phthalic acid anhydride to isolate androstenol-17-one-3 (testosterone); (7) isoandrostandiol-mono-acetate-17 obtained from iso-androstandiol-diacetate by partial hydrolysis, is oxidized with chromium trioxide and the androstanol-17-one-3 isolated by its semicarbazide; (8) iso-androstandiol-monoacetate-17-is treated as in example (7) except that use is not made of semicarbazone; (9) iso androstandiol-monobenzoate-17 is treated as in example (8); (10) 17-ethyl-androstendiol-3 : 17 is brominated, oxidized, and debrominated as described in example (4) to give D 5 : 6-17-ethyl-androstenol-17-one-3; (11) D 5 : 6-17-ethyl-androstendiol-3 : 17 is brominated, oxidized and debrominated as described in example (4) to give D 4 : 5-17-ethyl-androstenol-17-one-3; (12) 17-methyl-androstandiol-3 : 17-monoacetate-17 is oxidized with chromium trioxide to 17-methyl-androstanol - 17 - one - 3; (13) androstendiol-monobenzoate-17 is brominated, oxidized and debrominated as described in example (4) to give androstenol-17-one-3-benzoate-17, which on hydrolysis with dilute methyl alcoholic potash gives testosterone; (14) the 17-triphenylmethyl-ether of androstendiol-3-17 is brominated in pyridine solution and chromium trioxide in a small amount of water added. The reaction proceeds at room temperature for 2 days when it is debrominated with zinc dust to give androstenol-17-one-3.
GB2509235A 1935-09-09 1935-09-09 Process for the manufacture of androstenol-(17)-ones-(3) and derivatives thereof Expired GB464396A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2509235A GB464396A (en) 1935-09-09 1935-09-09 Process for the manufacture of androstenol-(17)-ones-(3) and derivatives thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2509235A GB464396A (en) 1935-09-09 1935-09-09 Process for the manufacture of androstenol-(17)-ones-(3) and derivatives thereof

Publications (1)

Publication Number Publication Date
GB464396A true GB464396A (en) 1937-04-09

Family

ID=10222075

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2509235A Expired GB464396A (en) 1935-09-09 1935-09-09 Process for the manufacture of androstenol-(17)-ones-(3) and derivatives thereof

Country Status (1)

Country Link
GB (1) GB464396A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2742485A (en) * 1954-01-15 1956-04-17 Francesco Vismara Societa Per Method for the preparation of testosterone and its esters

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2742485A (en) * 1954-01-15 1956-04-17 Francesco Vismara Societa Per Method for the preparation of testosterone and its esters

Similar Documents

Publication Publication Date Title
US2789989A (en) Preparation of 21-halo steroids
US2752366A (en) Carbonyloxysteroids
US2184299A (en) Keto cyclopentano dimethyl polyhydro phenanthroles and a method of producing the same
US2774776A (en) Dihalosteroids
US3210406A (en) A-norandrostenes and preparation thereof
GB464396A (en) Process for the manufacture of androstenol-(17)-ones-(3) and derivatives thereof
US2783254A (en) Process for the manufacture of 17alpha-hydroxycorticosterone and intermediates obtained thereby
US2562030A (en) Production of 17-hydroxy 20-keto steroid compounds
US2541074A (en) Preparation of derivatives of 3(alpha)-hydroxycholanic acid
US2601168A (en) delta 4-17alpha-methyl-3, 20-dioxo-pregnene compounds
US2875201A (en) Dehydrotigogenone intermediates
US3096350A (en) 6, 16alpha-dimethyl-delta1, 4, 6-pregnatriene-17alpha-ol-3, 20-dione and esters thereof
US3154569A (en) 19-nitrilosteroids and process for producing 19-norsteroids
US2408828A (en) Steroidal compounds and method for obtaining the same
US3231568A (en) Processes and intermediates for preparing 16alpha-methyl corticoids
US2686780A (en) Hydrolysis of 3, 20-diacyloxy-9 (11), 17 (20)-dioxido-5, 7-pregnadiene adducts
US2226627A (en) Sterols of the male sex hormone type
US2771476A (en) 11alpha-acyloxy-17alpha-halo-4-pregnene-3, 20-dione and process
US2231017A (en) Allo-pregnane compounds and method of obtaining the same
US2791593A (en) Preparation of 21-acyloxy-20-ketopregnanes
US2175220A (en) Androstendione and a method of producing the same
US2201121A (en) Unsaturated derivatives of compounds of the cyclopentano polyhydro phenanthrene series and a process of producing the same
US2780621A (en) Side chain degradation of 11-keto steroids
US3629302A (en) 6-chloro-20-substituted-pregnanes
US2283913A (en) Compounds of the cyclopentanopolyhydrophenanthrene series and a method for producing them